The Flowr Corporation is looking to service global cannabis markets from facilities in Canada, Australia and Portugal
Flowr is expanding globally in Portugal and Australia. The company has also inked a distribution partnership with Shoppers Drug Mart, and recently broke ground on a 50,000 sq. ft. R&D facility in Partnership with Scotts/Hawthorne.
The Flowr Corporation is a Toronto-headquartered cannabis company with operations in Canada, Europe, and Australia. Moreover, its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility that is currently under construction. From this campus, Flowr produces recreational and medicinal products. Further, internationally Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and will operate GMP-designed manufacturing facilities in Portugal and Australia.
Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products.
For more information on The Flowr Corporation (FLWR:TSX.V, FLWPF:OTC) please fill out the form below.